Evommune, Inc.
EVMNNYSEHealthcareBiotechnology
As of Oct 16, 2026 close
- Market cap
- $214.28M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $5.64$33.20
- Volume (live)
- -
- Avg. volume (3M)
- 924.80K
Evommune (EVMN) Stock Price & Financial Analysis
Evommune Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $5.09 - $6.00 |
|---|---|
| 52-Week High | $33.20 |
| 52-Week Low | $5.64 |
| Open | $5.97 |
| Volume (last close) | 986.36K |
| Average Volume (3M) | 924.80K |
| Revenue (TTM) | 10.00M |
|---|---|
| Net Income (TTM) | -94.67M |
| Free Cash Flow (TTM) | -74.65M |
| EPS (TTM) | −$2.88 |
| Profit Margin | -946.68% |
| Operating Margin | -1018.93% |
| Return on Equity (ROE) | -34.10% |
| Debt to Equity | 0.03 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 214.28M |
|---|---|
| Shares Outstanding | 36.14M |
| Price to Sales (P/S) | 21.43 |
| Price to Book (P/B) | 0.77 |
| EV/EBITDA | -1.68 |
| 50-Day MA | $10.82 |
|---|---|
| 200-Day MA | $18.52 |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
Evommune at a Glance
As of the Oct 16, 2026 close, Evommune (EVMN) has a market capitalization of $214.28M. The stock trades at 21.4× sales. Over the trailing twelve months it lost $94.67M on revenue of $10.00M and burned $74.65M of free cash flow. Revenue grew 233.3% year over year.
As of its latest reported balance sheet, it holds $60.03M in cash and securities against $8.11M of debt, a net cash position of $51.92M.
Evommune does not currently pay a dividend.
At $5.17 (the Oct 16, 2026 close) it sits near the bottom of its 52-week range of $5.64 to $33.20, below its 200-day moving average of $18.52.
Based on 12 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $24.00, 364.2% above the Oct 16, 2026 close.
Frequently Asked Questions About Evommune
What is the current stock price for EVMN?
As of the Oct 16, 2026 close, EVMN stock trades at $5.17. The 52-week range is $5.64–$33.20, with a day range of $5.09–$6.00.
What is the P/E ratio for EVMN?
The P/E ratio (Price-to-Earnings) for EVMN is shown in the Key Statistics section. This valuation metric helps compare Evommune, Inc. to industry peers.
Does EVMN pay dividends?
Evommune does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for EVMN?
Based on ratings from 12 professional analysts over the last 90 days, the consensus for EVMN is Buy. The average 12-month price target is $24.00, a 364.2% upside from the Oct 16, 2026 close of $5.17.
What is the market cap of EVMN?
As of the Oct 16, 2026 close, Evommune's market capitalization is $186.8M, classifying it as a micro-cap company. Evommune operates in the Healthcare sector within the Biotechnology industry.